Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study

Author: Rodon Jordi   Garrison Mitchell   Hammond Lisa   Bono Johann   Smith Lon   Forero Leonardo   Hao Desirée   Takimoto Chris   Lambert John   Pandite Lini   Howard Maria   Xie Hongsheng   Tolcher Anthony  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.62, Iss.5, 2008-10, pp. : 911-919

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content